Participant 16: EATRIS ERIC (EATRIS), The Netherlands

PI: Anton Ussi

EATRIS, the European Infrastructure for Translational Research offers a new collaboration model for fostering innovation. The infrastructure plays a fundamental role in the advancement of knowledge and technology in translational research, drug development and Personalised Medicine. With over 90 leading institutes, across 12 EU Member States, EATRIS provides access to the entire pipeline of academic translational infrastructure and expertise, and optimises the innovation route from discovery to proof-of-concept in medicines development and Personalised Medicine. It provides a new development pathway, open to researchers and companies in need of support for advancing biomedical innovations and improving human health.

The EATRIS ‘Coordination & Support’ office employs 17 staff people, with expertise ranging from biomedical project management, technology transfer to translational product development. EATRIS is a European Research Infrastructure Consortium (ERIC), a legal entity established by the European Commission to facilitate the operation of international research infrastructures. EATRIS is a member of the Personalised Medicine Coalition and partners with charities and patient organisations.

EATRIS will participate in WP6, WP8 (WP co-leader), and WP9.